Creative Medical Technology Holdings, Inc. Interest Expense, Other
Creative Medical Technology Holdings, Inc. (CELZ) reported Interest Expense, Other of $1.76 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2022-08-12
- Creative Medical Technology Holdings, Inc. interest expense, other for the quarter ending 2021-09-30 was $1.64M.
- Creative Medical Technology Holdings, Inc. interest expense, other for the quarter ending 2021-06-30 was -$113.23K.
- Creative Medical Technology Holdings, Inc. interest expense, other for the quarter ending 2021-03-31 was $231.23K.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 6 month as first filed | Interest Expense, Other 9 month |
|---|---|---|---|---|
| 2021-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.52M derived: sum of 2 quarters · filed 2022-08-12 | $1.76M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$113.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $118.00K 10-Q · filed 2022-08-12 | $543.92K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $231.23K 10-Q · filed 2022-05-13 | |||
| 2020-09-30 | $804.90K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |